These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 19165641)

  • 1. In response to 'Behind EUD'.
    Mavroidis P; Lind BK
    Acta Oncol; 2009; 48(4):610-4; author reply 614-7. PubMed ID: 19165641
    [No Abstract]   [Full Text] [Related]  

  • 2. Behind EUD.
    Wang JZ; Mayr NA; Yuh WT
    Acta Oncol; 2008; 47(5):971-2. PubMed ID: 18568489
    [No Abstract]   [Full Text] [Related]  

  • 3. Equivalent uniform dose for accelerated partial breast irradiation using the MammoSite applicator.
    Stewart AJ; Hepel JT; O'Farrell DA; Devlin PM; Price LL; Dale RG; Wazer DE
    Radiother Oncol; 2013 Aug; 108(2):232-5. PubMed ID: 23891101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical radiobiology of brachytherapy.
    Dale RG; Jones B
    Br J Radiol; 1998 May; 71(845):465-83. PubMed ID: 9691890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of predicted and clinical response to radiotherapy: a radiobiology modelling study.
    Hedman M; Bjork-Eriksson T; Mercke C; West C; Hesselius P; Brodin O
    Acta Oncol; 2009; 48(4):584-90. PubMed ID: 19107620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of an advanced brachytherapy planning system with a personal computer. I. Evaluations of the system from accuracy of calculations].
    Ogawa K; Kunieda E; Dokiya T; Wada T; Hashimoto S
    Nihon Igaku Hoshasen Gakkai Zasshi; 1987 Jul; 47(7):945-53. PubMed ID: 3658664
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of external beam radiotherapy and brachytherapy for localized prostate cancer using equivalent uniform dose.
    Wang JZ; Li XA
    Med Phys; 2003 Jan; 30(1):34-40. PubMed ID: 12557976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mathematical model of tumor evolution in radiotherapy].
    Liang B; Wen W; Wang B; Cao M; Zhan W
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2012 Dec; 29(6):1094-7. PubMed ID: 23469537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetric and radiobiological impact of dose fractionation on respiratory motion induced IMRT delivery errors: a volumetric dose measurement study.
    Duan J; Shen S; Fiveash JB; Popple RA; Brezovich IA
    Med Phys; 2006 May; 33(5):1380-7. PubMed ID: 16752574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EUD-based biological optimization for carbon ion therapy.
    Brüningk SC; Kamp F; Wilkens JJ
    Med Phys; 2015 Nov; 42(11):6248-57. PubMed ID: 26520717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Delineation of organs at risk and dose constraints].
    Noël G; Antoni D; Barillot I; Chauvet B
    Cancer Radiother; 2016 Sep; 20 Suppl():S36-60. PubMed ID: 27516050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The implementation of the Gynaecological Groupe Européen de Curiethérapie - European Society for Therapeutic Radiology and Oncology radiobiology considerations in the conversion of low dose rate to pulsed dose rate treatment schedules for gynaecological brachytherapy.
    Baker S; Pooler A; Hendry J; Davidson S
    Clin Oncol (R Coll Radiol); 2013 Apr; 25(4):265-71. PubMed ID: 23218875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The half-life of high dose rate Ir-192 sources.
    Podgorsak MB; DeWerd LA; Paliwal BR
    Med Phys; 1993; 20(4):1257-9. PubMed ID: 8413038
    [No Abstract]   [Full Text] [Related]  

  • 14. Normal tissue toxicity after small field hypofractionated stereotactic body radiation.
    Milano MT; Constine LS; Okunieff P
    Radiat Oncol; 2008 Oct; 3():36. PubMed ID: 18976463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twenty years of radiobiology in clinical practice: the Italian contribution.
    Strigari L; Caivano R; Avanzo M; Cremonesi M; Arrichiello C; Bianchi C; Botta F; Califano G; Ciscognetti N; D'Alessio D; D'Ambrosio L; D'Andrea M; Falco D; Guerriero F; Guerrisi M; Mola D; Pressello MC; Sarnelli A; Spiazzi L; Terlizzi A; Benassi M; Pedicini P
    Tumori; 2014; 100(6):625-35. PubMed ID: 25688496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mathematical modeling of optimal dose fields in radiotherapy of malignant tumors. Part 2 (Contact methods of radiotherapy)].
    Klepper LIa
    Med Tekh; 2004; (4):27-32. PubMed ID: 15455820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The theoretical benefit of beam fringe compensation and field size reduction for iso-normal tissue complication probability dose escalation in radiotherapy of lung cancer.
    Engelsman M; Remeijer P; van Herk M; Mijnheer B; Damen E
    Med Phys; 2003 Jun; 30(6):1086-95. PubMed ID: 12852532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor hypoxia is an important mechanism of radioresistance in hypofractionated radiotherapy and must be considered in the treatment planning process.
    Carlson DJ; Yenice KM; Orton CG
    Med Phys; 2011 Dec; 38(12):6347-50. PubMed ID: 22149817
    [No Abstract]   [Full Text] [Related]  

  • 19. On cold spots in tumor subvolumes.
    Tomé WA; Fowler JF
    Med Phys; 2002 Jul; 29(7):1590-8. PubMed ID: 12148742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analytical investigation of the possibility of parameter invariant TCP-based radiation therapy plan ranking.
    Stavreva N; Nahum A; Markov K; Ruggieri R; Stavrev P
    Acta Oncol; 2010 Nov; 49(8):1324-33. PubMed ID: 20950227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.